Plain-English translation of NCT07294664 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , an immunotherapy medication, combined with either a drug called or another drug called , along with standard chemotherapy. The goal is to see if these combinations work better than immunotherapy and chemotherapy alone for people with advanced stomach cancer.
Many people with advanced stomach cancer don't respond well enough to current immunotherapy and chemotherapy treatments. This study is trying to find out whether adding these new medications can help more patients benefit and live longer.
You likely qualify if…
You likely don't qualify if…
You would receive the study medications (either one of two combinations) through infusions and/or injections along with chemotherapy pills, typically over several weeks of treatment cycles. You would have regular doctor visits, blood tests, and imaging scans to monitor how well the treatment is working and watch for side effects. The study involves 78 participants total, and researchers will also ask you to provide blood samples and possibly tumor tissue samples to help them understand how the medications work.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China